-+ 0.00%
-+ 0.00%
-+ 0.00%

Futura Medical's Board to Kick Off Formal Sale Process

MT Newswires·09/03/2026 03:39:53
Listen to the news
03:39 AM EDT, 09/03/2026 (MT Newswires) -- Futura Medical (FUM.L) said Thursday that its board decided to commence a merger and acquisition and a formal sale process for the sexual health products company. The board believes the company's current market valuation does not adequately reflect the strategic value and commercial potential of its portfolio, which includes Eroxon and development projects WSD4000 and Eroxon Intense. Further, the company conditionally raised 1.6 million pounds sterling through a placing and a subscription of 801 million new shares. It also plans to raise up to 150,000 pounds through a retail offering of 75 million shares. The fundraising remains subject to shareholder approval. The company expects the proceeds to provide cash resources through February 2027, allowing it to explore the formal sale process.